Nuo Therapeutics, Inc. (AURX)

SG&A Expenses

$5.07M

TTM · Period ending: · USD

AURX logo

AURX SG&A Expenses

Latest reported$5.07M
AURX SG&A Expenses ($244.97K → $5.07M)
High-resolution chart · PNG

AURX sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
4,734,605
3,520,166
3,650,707
3,413,630
90,670
378,059
819,576
2,136,112
4,536,664
7,125,438
15,258,026
15,661,378
17,414,918
16,157,964
7,936,414
7,285,376
4,829,353
5,694,853
6,445,990
5,092,834
8,079,235
8,622,124
4,460,195
2,000,815
1,752,806
1,792,734
244,965
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.